Business
Dimethyltryptamine continues to demonstrate tremendous therapeutic potential
Hi, what are you looking for?
Mugglehead Investment Magazine
Research
Canada
The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients
Cannabis
Canadian company set to focus clinical trials down under, announces regulatory update
Psychedelics
As rates of mental health disorders increase the demand for psychedelic treatments do too
Analysis
According to a recent report, 47 per cent of cannabis marketers reported having annual budgets less than $50,000
Cannabis
Company growth within Colombia and Europe responsible for financial success this quarter
Canada
MyHempisphere program to be tailored to each customer
Cannabis
Industry is set to expand by approximately US$155 billion between 2020-2030
Cannabis
Many distributors are choosing not to test their products for microbes, pesticides and heavy metals
Analysis
Price is the main reason consumers purchase illegal cannabis, according to a recent report in the Journal of Studies on Alcohol and Drugs
